Synapse - Works

Results (5712)

Interviews of patients (Pts) with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) enrolled in 2 lisocabtagene maraleucel (liso-cel) trials on their treatment experience for 3 months after infusion

Meeting Abstract

Siddiqi, T.; Jaeger, U.; Moshkovich, O.; Braverman, J.; Liu, F. F.; Lanar, S.; Miera, M.; Shah, S.; Devlen, J.; Salles, G.
Blood (2021)

Fulltext@MSK | Save

Estimating selection bias in previous monoclonal gammopathy of undetermined significance research - the importance of screening: Results from the population-based screening study Iceland screens, treats or prevents multiple myeloma (iStopMM)

Meeting Abstract

Sigurbergsdóttir, A. Ý.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Sverrisdottir, I. S.; Sigurdardottir, G. A.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Thorsteinsdottir, I.; more...
Blood (2021)

Fulltext@MSK | Save

Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center

Meeting Abstract

Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
Blood (2021)

Fulltext@MSK | Save

Expert curation of somatic FLT3 variants by the ClinGen somatic hematologic cancer taskforce (ClinGen HCT)

Meeting Abstract

Shao, X.; Rao, S.; Mani, C.; Saliba, J.; He, R.; Kesserwan, C.; Danos, A.; Sheta, L.; Terraf, P.; Raca, G.; more...
Blood (2021)

Fulltext@MSK | Save

Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures

Meeting Abstract

Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
Blood (2021)

Fulltext@MSK | Save

Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in patients with relapsed/refractory B-cell malignancies

Meeting Abstract

Shah, B. D.; Jacobson, C.; Solomon, S. R.; Jain, N.; Johnson, M. C.; Vainorius, M.; Yu, L.; Heery, C. R.; List, A. F.; He, F.; more...
Blood (2021)

Fulltext@MSK | Save

A pilot plant-based dietary intervention in overweight and obese patients with monoclonal gammopathy of undetermined significance and smoldering multiple myeloma- the Nutrition Prevention (NUTRIVENTION) study

Meeting Abstract

Shah, U. A.; Alicea, D.; Adintori, P. A.; Burge, M.; Blaslov, J.; Derkach, A.; Mailankody, S.; Korde, N.; Tan, C.; Hultcrantz, M.; more...
Blood (2021)

Fulltext@MSK | Save

Safety, tolerability, PK/PD and preliminary efficacy of NKTR-255, a novel IL-15 receptor agonist, in patients with relapsed/refractory hematologic malignancies

Meeting Abstract

Shah, N.; Tan, A.; Budde, E.; Hofmeister, C. C.; Cowan, A. J.; Perales, M. A.; Choi, T.; Saeed, H.; Chavez, J. C.; Ye, J. C.; more...
Blood (2021)

Fulltext@MSK | Save

Novel single agents are equivalent to conventional chemotherapy inpatients with relapsed and refractory mature T-cell lymphomas: A meta-analysis

Meeting Abstract

Shafagati, N.; Stuver, R. N.; Boussi, L.; Koh, M. J.; Park, A.; Bain, P.; Foss, F. M.; Shen, C. Y.; Jain, S.
Blood (2021)

Fulltext@MSK | Save

Health-related quality of life and symptoms among patients with relapsed or refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice: Results from a randomized phase 3 trial

Meeting Abstract

Sanchorawala, V.; Wechalekar, A. D.; Kim, K.; Schönland, S.; Landau, H. J.; Fiona, K.; Suzuki, K.; Dispenzieri, A.; Merlini, G.; Comenzo, R.; more...
Blood (2021)

Fulltext@MSK | Save